February 18, 2026 · Form 4 insider transaction
GEMAYEL GEORGES bought 2,989 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027.